The ASX dusted itself off after a brutal $63bn wipeout, with global markets rebounding and commodities and even crypto ...

The ASX clawed back as tech stocks bounced, but oil jitters from the Iran crisis, and China’s weaker growth outlook kept ...

A global maternal care and infant feeding company based in Greater Washington has a new CEO. She's plotting some changes for ...

Novartis agreed to acquire clinical-stage biopharmaceutical maker Tourmaline Bio Inc. in an all-cash deal worth around $1.4 billion.

PFAS is a threat to firefighters’ health. Forever Analytical has launched a new screening program for firefighters, ...

Early Access Sparks 24‑Hour Rush for Clubs, Colleges, and Early Subscribers We designed the Big Apple Triathlon to ...

Technical advancement in taste-modification technology provides a fast-dissolving solution for sugar-free dietary ...

A homegrown biopharma developing cell therapies for cancers and other diseases is set to be acquired by Gilead Sciences — for ...

Rep. Valerie Foushee benefited from millions in super PAC dollars in 2022. Now she’s being massively outspent by a progressive primary challenger.

Unity's stock price cratered today on disappointing Q1 guidance. Here's why U shares aren't attractive to buy on the post-earnings dip. Unity Software is now down more than 50% versus its 52-week high ...